Session

Complications of cirrhosis

CAUSE-SPECIFIC MORTALITY OF PATIENTS WITH CIRRHOSIS IN ENGALND: VARIATION BY AETIOLOGY

Sonia Ratib, Kate Mary Fleming, Alex John Walker, Joe West, Colin J. Crooks

COMPARISON OF SEVEN PROGNOSTIC MODELS FOR SHORT-TERM MORTALITY IN BIOPSY-PROVEN ALCOHOLIC HEPATITIS.

Vasilios Papastergiou, Stylianos Karatapanis, Emmanuel Tsochatzis, Evangelos Thalassinos, Giulia Pieri, Andrew K. Burroughs

EARLY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) AS COMPARED TO ENDOSCOPIC TREATMENT REDUCES REBLEEDING BUT NOT MORTALITY IN CIRRHOTIC PATIENTS WITH A 1ST OR 2ND EPISODE OF VARICEAL BLEEDING: A MULTICENTRE RANDOMIZED CONTROLLED TRIAL

Ingrid Lisanne Holster, Adriaan Moelker, Eric T.T.L. Tjwa, Alexandra Wils, Peter Pattynama, Ernst J. Kuipers, Henk R. van Buuren

EFFECT'S EVALUATION OF THE TREATMENT WITH PROPRANOLOL AND LOW DOSE LOSARTAN VERSUS ONLY PROPRANOLOL ADMINISTRATION ON HEPATIC HAEMODYNAMIC PARAMETERS IN PATIENTS WITH LIVER CIRRHOSIS

Eugen Tcaciuc, Olga Corlateanu

THE PHOSPHODIESTERASE-5-INHIBITOR UDENAFIL - A NEW OPTION FOR THERAPY OF PORTAL HYPERTENSION

Wolfgang Kreisel, Peter Deibert, Limas Kupcinskas, Beate Appenrodt, Michaela Neagu, Martin Rössle, Alexander Zipprich, Karel Caca, Arnulf Ferlitsch, Ralf Mohrbacher, Roland Greinwald, Tilman Sauerbruch, Jolanta Šumskienė

THE PROGNOSTIC SIGNIFICANCE OF BACTERIAL DNA IN ASCITIC FLUID FROM CRITICALLY ILL CIRRHOTIC PATIENTS

Tony Bruns, Philipp A Reuken, Ludmila Gerber, Beate Appenrodt, Jack Peter, Andreas Herrmann, Frank Lammert, Stefan Zeuzem, Andreas Stallmach

Item 1 - 6 / 6
1